An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Insulet to Present at Nasdaq’s 45th Investor Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Insulet Corporation (NASDAQ: PODD) announced its participation in the 45th Nasdaq Investor Conference on December 3, 2021, at 11:30 a.m. ET. The presentation will be held virtually, and investors can access the live webcast at investors.insulet.com/events, with a replay available post-event. Insulet is renowned for its tubeless insulin pump technology through its Omnipod product line, focusing on simplifying diabetes management with its innovative, needle-free delivery system.
Positive
None.
Negative
None.
ACTON, Mass.--(BUSINESS WIRE)--
Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at the virtual 45thNasdaq Investor Conference on Friday, December 3, 2021 at 11:30 a.m. (Eastern Time).
To listen to the live webcast of the presentation, please visit investors.insulet.com/events. A replay of the webcast will also be available following the event.
About Insulet Corporation:
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit: insulet.com and omnipod.com.
When will Insulet Corporation present at the Nasdaq Investor Conference?
Insulet Corporation will present at the Nasdaq Investor Conference on December 3, 2021, at 11:30 a.m. ET.
How can I access the Insulet Corporation presentation during the Nasdaq Investor Conference?
You can access the live webcast of Insulet Corporation's presentation at investors.insulet.com/events.
What is the focus of Insulet Corporation's product line?
Insulet Corporation focuses on tubeless insulin pump technology with its Omnipod product line, designed to simplify life for people with diabetes.
What is the ticker symbol for Insulet Corporation?
The ticker symbol for Insulet Corporation is PODD.
What innovative feature does the Omnipod Insulin Management System offer?
The Omnipod Insulin Management System offers a simple, wearable design that allows for up to three days of non-stop insulin delivery without the need for needles.
